Physician

Jaclyn Kovach, MD

According to 2025 Medicare claims, Jaclyn Kovach, MD (NPI: 1174530323) practices ophthalmology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is UNIVERSITY OF MIAMI (NPI: 1073550398; TIN: 592579938) and primary practice location at 34103-3504.

Kovach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,717 traditional Medicare patients, billed 56,294 HCPCS/CPT codes, and received $3,259,269 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 805 prescription claims across 206 beneficiaries totaling $99,106 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 52 records totaling $107,827. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,635,921 to $3,259,269. In contrast, Part D prescription costs have declined steadily, from $135,744 to $99,106. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.3M2015 Medicare payment: $1,635,921 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,912,907 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,053,528 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,356,411 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,635,922 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,720,513 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,796,963 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,924,313 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,122,255 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,259,269 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,85210,187$1,635,921
20161,73510,531$1,912,907
20171,63811,111$2,053,528
20181,78212,240$2,356,411
20191,84613,058$2,635,922
20201,54912,470$2,720,513
20211,73513,075$2,796,963
20221,59515,677$2,924,313
20231,69946,484$3,122,255
20241,71756,294$3,259,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$149K$298K2015 Drug cost: $135,744 (USD; Tot_Drug_Cst)2016 Drug cost: $177,327 (USD; Tot_Drug_Cst)2017 Drug cost: $297,976 (USD; Tot_Drug_Cst)2018 Drug cost: $207,698 (USD; Tot_Drug_Cst)2019 Drug cost: $159,279 (USD; Tot_Drug_Cst)2020 Drug cost: $147,393 (USD; Tot_Drug_Cst)2021 Drug cost: $151,593 (USD; Tot_Drug_Cst)2022 Drug cost: $146,325 (USD; Tot_Drug_Cst)2023 Drug cost: $114,401 (USD; Tot_Drug_Cst)2024 Drug cost: $99,106 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153211,255$135,744
20163011,547$177,327
20172621,241$297,976
20182521,143$207,698
2019247945$159,279
20202701,043$147,393
20212511,048$151,593
2022224903$146,325
2023199753$114,401
2024206805$99,106

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3931,601$98
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7541,571$95
92014Established patient complete exam of visual system9771,459$85
92134Imaging of retina1,0732,705$30
92250Photography of the retina613797$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine261,380$23,890
NevanacNepafenac18691$16,356
TravoprostTravoprost391,812$5,823
Brimonidine TartrateBrimonidine Tartrate241,400$4,839
Prednisolone AcetatePrednisolone Acetate1103,735$3,352

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.48$70,406Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.4$37,421Alexion Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jaclyn Kovach, MD?

Tedicare shows public-source Medicare data for Jaclyn Kovach, MD (NPI 1174530323), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jaclyn Kovach, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jaclyn Kovach, MD?

Jaclyn Kovach, MD is linked to UNIVERSITY OF MIAMI (billing NPI 1073550398) in the available physician profile data.

Does Jaclyn Kovach, MD have Open Payments data?

Jaclyn Kovach, MD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.